Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 480251, 4 pages
http://dx.doi.org/10.1155/2012/480251
Research Article

BDKRB2 +9/−9 Polymorphism Is Associated with Higher Risk for Diabetes Mellitus in the Brazilian General Population

1Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), University of Sao Paulo Medical School, Avenida Dr. Enéas de Carvalho Aguiar, 44 Cerqueira César, 05403-000 São Paulo, SP, Brazil
2Department of Medicine, Ouro Preto Federal University, Ouro Preto, MG, Brazil
3Department of Physiology, Espirito Santo Federal University, Vitória, ES, Brazil

Received 3 October 2012; Accepted 1 November 2012

Academic Editor: Aristidis Veves

Copyright © 2012 Rafael de Oliveira Alvim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Regoli and J. Barabé, “Pharmacology of bradykinin and related kinins,” Pharmacological Reviews, vol. 32, no. 1, pp. 1–46, 1980. View at Google Scholar · View at Scopus
  2. E. S. M. Rocha, W. T. Beraldo, and G. Rosenfeld, “Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin,” American Journal of Physiology, vol. 156, pp. 261–273, 1949. View at Google Scholar
  3. T. Shiuchi, T. X. Cui, L. Wu et al., “ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO,” Hypertension, vol. 40, no. 3, pp. 329–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Beck-Nielsen and L. C. Groop, “Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus,” Journal of Clinical Investigation, vol. 94, no. 5, pp. 1714–1721, 1994. View at Google Scholar · View at Scopus
  5. I. Duka, S. Shenouda, C. Johns, E. Kintsurashvili, I. Gavras, and H. Gavras, “Role of the B2 receptor of bradykinin in insulin sensitivity,” Hypertension, vol. 38, no. 6, pp. 1355–1360, 2001. View at Google Scholar · View at Scopus
  6. A. Braun, S. Kammerer, E. Maier, E. Böhme, and A. A. Röscher, “Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases,” Immunopharmacology, vol. 33, no. 1–3, pp. 32–35, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Lung, E. K. L. Chan, and B. L. Zuraw, “Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency,” Journal of Allergy and Clinical Immunology, vol. 99, no. 1 I, pp. 134–146, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Makdisse, A. D. C. Pereira, D. D. P. Brasil et al., “Prevalence and risk factors associated with peripheral arterial disease in the hearts of Brazil project,” Arquivos Brasileiros de Cardiologia, vol. 91, no. 6, pp. 370–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. C. J. L. Santos, R. A. G. Soares, D. B. G. Santos et al., “CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population,” BMC Medical Genetics, vol. 19, no. 12, article 13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. G. Soares, P. C. J. L. Santos, G. L. L. MacHado-Coelho et al., “CYP2C9 and VKORC1 polymorphisms are differently distributed in the brazilian population according to self-declared ethnicity or genetic ancestry,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 8, pp. 957–963, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. “1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.,” Journal of Hypertension, vol. 17, no. 2, pp. 151–183, 1999. View at Scopus
  12. “Executive summary: standards of medical care in diabetes—2011,” Diabetes Care, vol. 34, supplement1, pp. S4–S10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kammerer, A. Braun, N. Arnold, and A. A. Roscher, “The human bradykinin B2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region,” Biochemical and Biophysical Research Communications, vol. 211, no. 1, pp. 226–233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. E. J. Henriksen, S. Jacob, H. J. Augustin, and G. J. Dietze, “Glucose transport activity in insulin-resistant rat muscle: effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism,” Diabetes, vol. 45, no. 1, pp. S125–S128, 1996. View at Google Scholar · View at Scopus
  15. G. Doetze and M. Wicklmayr, “Evidence for a participation of the kallikrein kinin system in the regulation of muscle metabolism during muscular work,” FEBS Letters, vol. 74, no. 2, pp. 205–208, 1977. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Yang and W. H. Hsu, “Stimulatory effect of bradykinin on insulin release from the perfused rat pancreas,” American Journal of Physiology, vol. 268, no. 5, pp. E1027–E1030, 1995. View at Google Scholar · View at Scopus
  17. P. Iozzo, A. Viljanen, M. A. Guzzardi et al., “The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 7, pp. E1192–E1196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Uehara, H. Kishikawa, S. Isami et al., “Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans,” Diabetologia, vol. 37, no. 3, pp. 300–307, 1994. View at Google Scholar · View at Scopus
  19. R. O. Alvim, P. C. J. L. Santos, N. E. Ferreira, J. G. Mill, J. E. Krieger, and A. C. Pereira, “Thioredoxin interacting protein (TXNIP) rs7212 polymorphism is associated with arterial stiffness in the Brazilian general population,” Journal of Human Hypertension, vol. 26, no. 5, pp. 340–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. C. J. De Lima Santos, R. De Oliveira Alvim, N. E. Ferreira et al., “Ethnicity and arterial stiffness in Brazil,” American Journal of Hypertension, vol. 24, no. 3, pp. 278–284, 2011. View at Publisher · View at Google Scholar · View at Scopus